Eurofarma

Eurofarma

Innovative pharmaceutical solutions enhancing health accessibility and quality of life.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
investor

€0.0

round
investor investor

€0.0

round
investor

€0.0

round
*
N/A

BRL3.0b

Debt
Total Funding000k
Notes (0)
More about Eurofarma
Made with AI
Edit

Eurofarma is a leading pharmaceutical company focused on making healthcare accessible and improving the quality of life for people. Operating primarily in the Latin American market, Eurofarma serves a diverse range of clients including hospitals, clinics, and individual consumers. The company’s business model revolves around the development, production, and distribution of a wide array of pharmaceutical products, from prescription medications to over-the-counter drugs. Revenue is generated through the sale of these products, as well as through partnerships and licensing agreements. Eurofarma is also deeply committed to social responsibility, with initiatives in environmental sustainability, education, and community health. Key projects include the Eurofarma Institute, which has provided over 77,000 consultations in areas such as complementary, environmental, and youth education. The company’s efforts in sustainability are highlighted by programs like the Sustainable Development Primer and initiatives to decontaminate medicine packaging at home. Eurofarma’s commitment to social causes is further exemplified by its Lactare project, encouraging breast milk donation to support infant health.

Keywords: pharmaceutical, healthcare, Latin America, prescription medications, over-the-counter drugs, sustainability, education, community health, partnerships, licensing.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Investments by Eurofarma

Edit
Dermage
ACQUISITION by Eurofarma Jun 2025
Medimetriks Pharmaceuticals
ACQUISITION by Eurofarma Nov 2022
Genfar
ACQUISITION by Eurofarma Mar 2023